Drug Type Biosimilar, Hormone |
Synonyms Insulin aspart 30 Biosimilar (Ningbo Kunpeng Biotechnology Co., Ltd.), 门冬胰岛素生物类似药(Ningbo Kunpeng Biotechnology Co., Ltd.) |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |


| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D04475 | - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus | IND Approval | China | 22 Aug 2024 |






